(EMAILWIRE.COM, August 22, 2024 ) According to the latest research by InsightAce Analytic, the Global Fecal Immunochemical Diagnostic Test (FIT) Market is valued at US$ 1.36 Bn in 2023, and it is expected to reach US$ 2.03 Bn by 2031, with a CAGR of 5.29% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2660
The fecal immunochemical diagnostic test (FIT) is a non-invasive way to check for blood in the poop that isnt visible. This could be a sign of colon cancer starting early or other digestive problems. The worldwide fecal immunochemical diagnostic test (FIT) market is propelled by the increased demand for non-invasive diagnostic technologies and the rising global prevalence of colorectal cancer. Due to its high accuracy, convenience, and patient acceptance, FIT has become the primary screening tool for colorectal cancer in several countries. The market is expected to experience accelerated development in the next years because of the anticipated increase in demand for FIT testing.
The fecal immunochemical diagnostic test (FIT) market is expected to experience expansion due to the increased awareness of colorectal cancer screening programs by governments and organizations. Promising prospects exist for market participants in creating fecal immunochemical diagnostic tests that are less expensive, more sensitive, and more specific. Companies invest heavily in researching and developing cutting-edge fecal immunochemical tests to gain a more significant portion of the market.
List of Prominent Players in the Fecal Immunochemical Diagnostic Test (FIT) Market:
Quest Diagnostics Incorporated
Sentinel CH. SPA
FUJIFILM Corporation
Quidel Corporation
Danaher (Beckman Coulter, Inc.)
Eiken Chemical Co., Ltd.
Freenome Holdings, Inc.
Immunostics, Inc.
BTNX, Inc.
Biohit Oyj
Market Dynamics:
Drivers:
The market for fecal immunochemical diagnostic tests (FIT) is growing because more people are learning about colon cancer screening and finding the disease early. FIT is a popular choice among both patients and healthcare providers because it is non-invasive, easy to use, and more accurate than other ways. Market growth is also driven by government programs and suggestions for regular colorectal cancer screening, as well as an older population that is more likely to get colorectal cancer. Better healthcare infrastructure and technological advances have also made FIT more popular and easier to get. This helps with early diagnosis and treatment results, driving market growth.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Challenges:
The fecal immunochemical diagnostic test (FIT) market has several challenges, including limited reimbursement rules and high-test costs that can restrict access for many patients. Reduced adoption rates result from a lack of general knowledge and education regarding the need for consistent colorectal cancer screening. Furthermore, discouraging some people from choosing FIT is due to variations in test accuracy and the necessity of follow-up actions should good results be shown. Further complicating market growth are logistical difficulties about sample collecting, handling, and processing. This slows down the development of the fecal immunochemical diagnostic test (FIT) market and causes possible health hazards due to a lack of testing and monitoring.
Regional Trends:
The North American fecal immunochemical diagnostic test (FIT) market is expected to register a major market share in terms of revenue. It is projected to grow at a high CAGR in the near future because of well-developed healthcare systems, more public understanding of the need for colon cancer screening, and robust government programs encouraging early diagnosis. Besides, Europe had a substantial share in the market due to heavy investment and measures that are favorable to the government and encourage frequent screening. Market strength is further enhanced by the existence of top diagnostic firms and the implementation of cutting-edge technology. Fecal immunochemical diagnostic tests are in high demand in Europe due to a number of factors, including the regions aging population and the rising incidence of gastrointestinal illnesses.
Recent Developments:
In July 2024, Quest Diagnostics, a frontrunner in the diagnostic information services industry, announced that it had reached an official agreement to acquire LifeLabs, a respected Canadian provider of community laboratory tests used by millions of Canadians, for a total consideration of around CAN $1.35 billion (approximately USD 985 million), including net debt.
In April 2024, QuidelOrtho, a worldwide leader in in vitro diagnostic technologies for point-of-care, clinical labs, and transfusion medicine, announced a software development partnership with BYG4lab®, a market leader in laboratory data management and middleware. The partnership will help QuidelOrtho speed up its efforts to enhance and broaden its informatics offerings across all of its diagnostics platforms.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2660
Segmentation of Fecal Immunochemical Diagnostic Test (FIT) Market-
Fecal Immunochemical Diagnostic Test (FIT) Market- By Product
Kits & Reagents
Analyzers
Others
Fecal Immunochemical Diagnostic Test (FIT) Market- By End-User
Hospitals & Diagnostics Laboratories
Specialty Clinics
Home Care Settings
Research Institutes
Fecal Immunochemical Diagnostic Test (FIT) Market- By Region
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
South East Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2660
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
